Intra-Cellular Therapies Inc. buy melinda
Start price
30.08.17
/
50%
€18.13
Target price
27.12.17
€25.00
Performance (%)
-14.01%
End price
27.12.17
€15.59
Summary
This prediction ended on 27.12.17 with a price of €15.59. The price of Intra-Cellular Therapies Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.01%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by melinda for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
ITCI auf dem richtigen Weg für die Einreichung der NDA bis Mitte 2018
(Vom Mitglied beendet)
Stopped prediction by melinda for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€11.81
04.04.19
04.04.19
€18.04
04.11.21
04.11.21
233.36%
05.11.21
05.11.21
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€16.35
30.08.17
30.08.17
€22.55
27.12.17
27.12.17
-14.01%
27.12.17
27.12.17